The dangerous drug attorneys at the Law Offices of Gregory Krasovsky can provide legal advice and representation to individuals and families considering pursuing a Trasylol lawsuit. In order for a plaintiff to secure a maximum settlement in litigation of a Trasylol claim, regardless of whether in an individual lawsuit or in a class action lawsuit, it is crucial that the law firm representing you have a competent and experienced team of Trasylol lawyers to guide you through all of the legal hurdles as well as direct you to sufficient funding (litigation funding or legal finance) to cover pharmaceutical litigation costs. Contact a Trasylol attorney today to schedule a free consultation and take your first step to obtaining compensation for losses caused by Trasylol side effects.

Trasylol, which is Bayer's brand name for the drug Aprontinin, is a basic pancreatic trypsin inhibitor (BPTI), which inhibits trypsin and other proteolytic enzymes. Trasylol is used is generally used in open-hear surgeries. Since Bayer introduced this drug in 1993, it has been used in about a third of all open-heart surgeries in order to prevent blood loss. Although many people have died as a result of Trasylol, many attorneys suspect that Bayer was illicitly covering up the deadly side effects of Trasylol.

Trasylol has had a tumultuous history over the last few years. The controversy has centered around a list of potentially fatal Trasylol adverse effects, which include:

• Kidney Failure

• Heart Attack

• Stroke

• Congestive Heart Failure

Apparently, Bayer was aware that Trasylol could cause all of these side effects. Bayer conducted its own study, which found that Trasylol is in fact a dangerous drug, but Bayer did not furnish the Food and Drug Administration with this report when Dr. Dennis Mangano, in 2006, presented his findings about the dangerous side effects to the FDA. After the FDA received this report, it added a black box warning label to Trasylol warning patients and doctors about the side effects.

Studies have found that the risk of death is 64% higher with Trasylol than it is with comparable drugs that could be used in its stead.

Even though the FDA initially let Trasylol stay on the market, a few months later, when the FDA found out that the Canadian Board of Health barred the use of Trasylol, the FDA reversed its decision and barred its use. Bayer, however, preemptively withdrew the drug from the market on November 5, 2007. From that point on, Trasylol was used in only very restricted circumstances.

The European Medicines Agency (EMA) had at one point barred the use of Trasylol, but subsequently, it had allowed it to return to the market, in February 2012.

If you or a loved one has been injured by taking Trasylol, then you might be entitled to significant compensation in a Trasylol settlement. A Trasylol law firm can help you secure that settlement that you deserve. Contact one of our unsafe drug lawyers today to schedule a free and confidential consultation and take the first step to recovering damages and recovering normalcy in your life.